Skip to main content
Premium Trial:

Request an Annual Quote

NimbleGen Raises $12.8 Million in Venture Capital Round

NEW YORK, Nov. 1 (GenomeWeb News) - NimbleGen Systems has raised $12.75 million in a series F round of venture capital financing, the company said today.

 

Current investors Baird Venture Partners and Venture Investors led the round; new investors included Cargill Ventures and Topspin Partners, as well as all of the company's other existing venture capital and institutional investors.

 

The new round brings to $41 million the total amount of private-equity financing NimbleGen has raised since its founding in 2000.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.